Adopting Serialization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Adopting Serialization
Serialized product codes serve as the foundation of ePedigree records and product traceability.


Pharmaceutical Technology
Volume 34, Issue 8

Beyond authentication

Serialized identification opens doors beyond authentication and product tracking. A smartphone application not only allows field investigators and consumers to scan or input the code from a package to confirm authenticity, but also can present the product's history and prompt the delivery of promotional information or link to a chat function or customer service.


Technology from Covectra can provide access to product information, including ePedigree records.
Other possible loyalty program services include instructions about how to take the product, dose reminders, and refill reminders. The smartphone application and the associated software and services also capture sales information for brand managers and can connect physicians and pharmacists to prescribing information. Deployable in 30 days, the software requires minimal commitment from corporate information-technology personnel for implementation (Brand Loyalty and Integrity Services, Covectra, Southborough, MA).

Mobile-phone-based technology and serialized codes on scratch-off tags have been tested in Africa. After transmitting the code, a message confirming product authenticity arrives within a few seconds (Mobile Product Authentication technology, Sproxil, Planada, CA, mPedigree, Accra, Ghana).


Hallie Forcinio
Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here